GlaxoSmithKline, Biogen Idec strike antibody deals with biotech startup Adimab

Ryan McBride Adimab has landed its two biggest licensing deals to date, and the undisclosed payments from the pacts have pushed its antibody-discovery business far into profitability. FierceBiotech ...

GlaxoSmithKline replaces head of business in China amid bribery investigation

Carly Helfand Against the backdrop of an ongoing government bribery probe in China, GlaxoSmithKline is shuffling its senior management there. Herve Gisserot is taking over. FiercePharma ...

GlaxoSmithKline to pay states $229M to wrap Avandia suits, other claims

Tracy Staton GlaxoSmithKline has wrapped up another set of Avandia lawsuits. The drugmaker said it reached a deal with 8 state attorneys general to resolve lawsuits involving the controversial ...

GlaxoSmithKline sales tick up, but China probe will hit growth

Tracy Staton GlaxoSmithKline's second-quarter results took a back seat to the goings-on in China. But sales are up just a tick. Profits dropped, falling short of analyst expectations. ...

GlaxoSmithKline CEO says HQ, British execs ‘knew nothing’ of China fraud

Tracy Staton GlaxoSmithKline CEO Andrew Witty faced a flurry of questions about China when he stood up to talk about second-quarter earnings–and he bowed out of the conference ...

GlaxoSmithKline forges ahead with hunt for Chinese vaccine partners

Tracy Staton GlaxoSmithKline may be suffering through a corruption scandal in China, but that hasn't interfered with its plans to team up with a Chinese company on vaccines. Its ...

GlaxoSmithKline exec admits ‘breaches,’ promises price cuts in China

Tracy Staton Sent to deal with the developing case personally, emerging markets chief Abbas Hussain met with ministry officials–and reportedly apologized to them. Afterward, Hussain ...

As bribery probe intensifies, China confines GlaxoSmithKline finance chief to its borders

Tracy Staton In the midst of investigating GSK for bribery, Chinese officials confined GSK finance chief Steve Nechelput to the country at the end of June, Reuters reports. His boss, ...

GlaxoSmithKline teams with Immunocore on next-gen cancer immunotherapies

John Carroll It took more than a decade for the executive team at Immunocore to achieve their first Big Pharma partnership for their new approach to developing revved up immunotherapies ...

GlaxoSmithKline faces new allegations over China Botox sales

Eric Palmer GlaxoSmithKline is denying allegations that its employees paid Chinese doctors bribes to prescribe drugs, Botox in particular. Even if the company runs afoul of Chinese ...

GlaxoSmithKline, J&J make early progress with monthly HIV remedies

Ryan McBride GlaxoSmithKline ($ GSK) and Johnson & Johnson ($ JNJ) have advanced development of injections that could provide HIV treatment without the burden of taking ...

Chinese police corral GlaxoSmithKline employees in bribery probe

Tracy Staton FiercePharma News
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS